Allison C. Chin

Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition

Brittney‐Shea Herbert, Ginelle C. Gellert, Amelia E. Hochreiter et al. · Oncogene · 2005 · 262 citations

Lipid Modification, Biochemistry, Natural Sciences +5

A novel telomerase template antagonist (GRN163) as a potential anticancer agent.

Akira Asai, Yuko Oshima, Yoshihiro Yamamoto et al. · PubMed · 2003 · 242 citations

Pathology, Initial Telomere Length, Pharmacotherapy +19

Role of patient and public involvement in implementation research: a consensus study

Kara Gray‐Burrows, Thomas A. Willis, Robbie Foy et al. · BMJ Quality & Safety · 2018 · 185 citations · Full text

Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes

Steven R. Fauce, Beth D. Jamieson, Allison C. Chin et al. · The Journal of Immunology · 2008 · 165 citations · Full text

Telomerase Antagonists GRN163 and GRN163L Inhibit Tumor Growth and Increase Chemosensitivity of Human Hepatoma *

Meta W. Djojosubroto, Allison C. Chin, Ning Go et al. · Hepatology · 2005 · 150 citations